“Provider undermines the physician’s ethical obligations, clinical integrity, and accountability, as well as trust in the patient–physician relationship.” — ACP Board of Regents

“If the systems of the site are compromised and being held for ransom, there would be no way to continue that trial, and [it would likely be] impossible to participate in other trials.” — Jeff Patton, MD, OneOncology

“The WOLVERINE meta-analysis provides the strongest evidence to date that MDT improves progression-free survival, radiographic progression-free survival, and castration resistance-free survival.” — Tang et al., The Lancet Oncology

“Patients with stage IB-IIIA or IIB disease should be considered for neoadjuvant and/or adjuvant systemic therapy based on biomarker testing for PD-L1 status, EGFR mutations, and ALK gene fusions.” — NCCN NSCLC Guidelines, Version 3, 2026

“Patients treated in the Optune Pax arm had a median time to pain progression of 15.2 months compared to 9.1 months.” — PANOVA-3 Trial, FDA Approval Announcement

When confronted with poor outcomes, hope remains essential, but defining it becomes more challenging. Nurses may struggle to understand how to incorporate hope into care, regardless of patient outcomes.